New knowledge on alendronate (Fosamax) and fractures
Kopjar, B.; Bjørndal, A.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 119(5): 702
1999
ISSN/ISBN: 0029-2001 PMID: 10095398 Document Number: 508744
Document emailed within 1 workday
Related Documents
Wynn, R.L. 2007: Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw? General Dentistry 55(6): 495-498Høiseth, A. 1999: Research philosophy and practical research--new knowledge about alendronate and fractures Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(11): 1648
Angthong, C.; Angthong, W. 2011: Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases Journal of the Medical Association of Thailand 94 Suppl. 7: S214-S220
Bamrungsong, T.; Pongchaiyakul, C. 2010: Bilateral atypical femoral fractures after long-term alendronate therapy: a case report Journal of the Medical Association of Thailand 93(5): 620-624
Arboleya, L.R.; Morales, A.; Fiter, J. 2000: Effect of alendronate on bone mineral density and incidence of fractures in postmenopausal women with osteoporosis. A meta-analysis of published studies Medicina Clinica 114 Suppl. 2: 79-84
Koryl'chuk, N.I.; Masyk, O.M.; Bilozets'ka-Smiian, S.I.; Slaba, U.S. 1999: The effect of fosamax on bone tissue function in patients with rheumatoid arthritis (based on x-ray densitometry data) Likars'ka Sprava 1: 117-119
Lee, S.-H.; 임윤택 2015: Identification of Knowledge Driven Production Path through ICTs Industry as a Tool of Knowledge Sharing and Knowledge Management in Knowledge City Journal of The Korean Urban Management Association 28(2): 409-434
Høiseth, A. 1998: Estrogen replacement is better than alendronate Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(14): 2216
Harada, A. 2009: Alendronate for treatment of osteoporoses Nihon Rinsho. Japanese Journal of Clinical Medicine 67(5): 943-947
Okano, T.; Teshima, R. 2003: Clinical trials of alendronate Nihon Rinsho. Japanese Journal of Clinical Medicine 61(2): 231-234
Tronci, S. 1998: Esophagitis due to alendronate. Report of two cases Minerva Gastroenterologica E Dietologica 44(3): 159-162
Kristiansen, I.S.; Falch, J.A.; Andersen, L.; Aursnes, I. 1997: Use of alendronate in osteoporosis--is it cost-effective? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(18): 2619-2622
Keen, R.W.; Spector, T.D. 1996: Alendronate: a new bisphosphonate for the treatment of osteoporosis British Journal of Clinical Practice 50(4): 211-217
Li, H.; Jia, G.-l.; Wang, H.-c.; Zhang, R.-q.; Tao, H.-r.; Lü, R.; Hu, T.; Wang, J. 2006: The effect of alendronate on arterial calcification in rat model Zhonghua Nei Ke Za Zhi 45(6): 489-492
Minisola, S.; Scillitani, A.; Romagnoli, E. 2006: Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis New England Journal of Medicine 355(20): 2156-2157; Author Reply 2157
Carrère, C.; Duval, J.-L.; Godard, B.; De Jaureguiberry, J.-P.; Ciribilli, J.-M. 2002: Severe acute hepatitis induced by alendronate Gastroenterologie Clinique et Biologique 26(2): 179-180
Mackay, F.; Mann, R.D. 1998: Tolerability of alendronate. Figures given in letter were prevalences, not incidences Bmj 316(7141): 1390
Minne, H.W.; Pöllhane, W.; Karpf, D.B. 1999: The effects of alendronate on stature and the spine deformity index International Journal of Clinical Practice. Suppl 101: 36-39
Wilke, D. 2014: Is high-dose, orally administered alendronate analgesic? Medizinische Monatsschrift für Pharmazeuten 37(12): 459-460
Jastrzebski, Z.; Napiórkowska, L.; Pykało, R. 2007: The histopathological evaluation of the local tolerance of alendronate containing medicines Endokrynologia Polska 58(1): 11-17